Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathryn C B Tan

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Cardiovascular & Hematological Disorders Drug Targets|June 23, 2007
Management of dyslipidemia in the metabolic syndromeKathryn C B Tan
Clinical Endocrinology|September 10, 2013
Outcomes of applying the NOF, NOGG and Taiwanese guidelines to a cohort of Chinese early postmenopausal womenElaine Cheung, Annie W C Kung, Kathryn C B Tan
Journal of Atherosclerosis and Thrombosis|August 7, 2012
Effect of advanced glycation end products on lectin-like oxidized low density lipoprotein receptor-1 expression in endothelial cellsSammy W M Shiu, Ying Wong, Kathryn C B Tan
Postgraduate Medical Journal|April 24, 2017
Absolute benefits of empagliflozin in type 2 diabetes: a game changer?Cyrus R Kumana, Kathryn C B Tan, Bernard M Y Cheung
Maturitas|June 17, 2018
Serum follicle stimulating hormone is associated with reduced risk of diabetes in postmenopausal women: The Hong Kong osteoporosis studyChing-Lung Cheung, Annie W C Kung, Kathryn C B Tan
International Journal of Epidemiology|October 13, 2017
Cohort Profile: The Hong Kong Osteoporosis Study and the follow-up studyChing-Lung Cheung, Kathryn C B Tan, Annie W C Kung
Atherosclerosis|November 9, 2004
Glycoxidized low-density lipoprotein regulates the expression of scavenger receptors in THP-1 macrophagesMichael C W Lam, Kathryn C B Tan, Karen S L Lam
Diabetes/Metabolism Research and Reviews|February 22, 2011
Serum advanced glycation end products (AGEs) are associated with insulin resistanceKathryn C B Tan, Sammy W M Shiu, Ying Wong, et al.
Journal of the Endocrine Society|April 30, 2021
Management of Familial Hypercholesterolemia: Current Status and Future PerspectivesDavid T W Lui, Alan C H Lee, Kathryn C B Tan
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 11, 2007
Increased serum advanced glycation end products are associated with impairment in HDL antioxidative capacity in diabetic nephropathyHuali Zhou, Kathryn C B Tan, Sammy W M Shiu, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Cardiovascular & Hematological Disorders Drug Targets|June 23, 2007
Management of dyslipidemia in the metabolic syndromeKathryn C B Tan
Clinical Endocrinology|September 10, 2013
Outcomes of applying the NOF, NOGG and Taiwanese guidelines to a cohort of Chinese early postmenopausal womenElaine Cheung, Annie W C Kung, Kathryn C B Tan
Journal of Atherosclerosis and Thrombosis|August 7, 2012
Effect of advanced glycation end products on lectin-like oxidized low density lipoprotein receptor-1 expression in endothelial cellsSammy W M Shiu, Ying Wong, Kathryn C B Tan
Postgraduate Medical Journal|April 24, 2017
Absolute benefits of empagliflozin in type 2 diabetes: a game changer?Cyrus R Kumana, Kathryn C B Tan, Bernard M Y Cheung
Maturitas|June 17, 2018
Serum follicle stimulating hormone is associated with reduced risk of diabetes in postmenopausal women: The Hong Kong osteoporosis studyChing-Lung Cheung, Annie W C Kung, Kathryn C B Tan
International Journal of Epidemiology|October 13, 2017
Cohort Profile: The Hong Kong Osteoporosis Study and the follow-up studyChing-Lung Cheung, Kathryn C B Tan, Annie W C Kung
Atherosclerosis|November 9, 2004
Glycoxidized low-density lipoprotein regulates the expression of scavenger receptors in THP-1 macrophagesMichael C W Lam, Kathryn C B Tan, Karen S L Lam
Diabetes/Metabolism Research and Reviews|February 22, 2011
Serum advanced glycation end products (AGEs) are associated with insulin resistanceKathryn C B Tan, Sammy W M Shiu, Ying Wong, et al.
Journal of the Endocrine Society|April 30, 2021
Management of Familial Hypercholesterolemia: Current Status and Future PerspectivesDavid T W Lui, Alan C H Lee, Kathryn C B Tan
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 11, 2007
Increased serum advanced glycation end products are associated with impairment in HDL antioxidative capacity in diabetic nephropathyHuali Zhou, Kathryn C B Tan, Sammy W M Shiu, et al.
Pageof 10